
How is the resistance of the anti-influenza drug "Baloxavir Marboxil"? The team led by Zhang Wenhong released a study
In recent years, there have been claims online about the antiviral drugs for influenza developing resistance. Is this claim true? Reporters learned from the infection department of Huashan Hospital affiliated with Fudan University, led by Zhang Wenhong, that his team, in collaboration with several domestic research institutions, has completed a real-world study covering nearly 4,000 Chinese patients. This study is the first to comprehensively assess the changes in the sensitivity of influenza viruses to the antiviral drug "Baloxavir marboxil" since its launch in China in 2021

